Title: Medical Advisor
Project: Revision of pathogen-specific antibiotic protocols for MSF
Duration: 9 months consultancy or 9 months contract
Reporting to: Leader ABR Task Force
Deadline for applications: 31st May 2018
Médecins Sans Frontières (MSF) is an international, independent, medical humanitarian organisation that delivers emergency aid to people affected by armed conflict, epidemics, healthcare exclusion and natural disasters. MSF offers assistance to people based only on need and irrespective of race, religion, gender or political affiliation.
MSF International is the legal entity that binds MSF’s 21 sections, 24 associations and other offices together. Based in Geneva, MSF International provides coordination, information and support to the MSF movement, and implements international projects and initiatives as requested.
As one of the pillars identified to address antibiotic resistance, Antibiotic Stewardship encompasses the rational use of antibiotics – specifically, the right antibiotic given for the right diagnosis, at the right dose, for the right duration, with de-escalation of broad-escalation of spectrum agents if and when possible.
Increasing numbers of projects within MSF are improving their access to microbiology. Existing MSF protocols for targeted pathogen-specific antibiotic prescription are outdated and need revision. These protocols are frequently adapted and re-written in an ad hoc, non-peer reviewed manner in many fields. In order to inform best practice for the field, there is a clear need to consolidate and revise existing antibiotic prescription protocols. This is a necessary step to ensure not only rational use of broad-spectrum antibiotics - which will be used with increasing frequency as ABR rates increase – but, importantly, to inform clinical practice to optimize patient outcomes and minimize toxicity associated with inappropriate antibiotic choice.
PLACE IN THE ORGANISATION
The position reports to the leader of the ABR task force.
OBJECTIVES OF THE POSITION
To develop a pathogen-based treatment protocol for projects with access to microbiology, focusing on sepsis, osteomyelitis, UTI and CNS infections, particularly in burns patients and those with renal impairment. The protocols should also include the basics on ATB use including dosing, dose adjustments for particular cases (including children, patients with burns), de-escalation, etc.
Revision of pathogen-specific antibiotic protocols (including treatment of MDR pathogens):